PetVivo Holdings to Provide Shareholders Update Meeting
PetVivo Holdings, Inc. (OTCQB: PETV and PETVW) is preparing to connect with its valued shareholders during a significant online event. The upcoming Shareholders Update Meeting will reflect on the company’s achievements in the ongoing fiscal year and present a vision for what lies ahead. This engaging session encourages interaction through a live webcast, making it easy for participants to stay informed about the company's growth and innovative strategies in the medical device industry focused on animals.
Event Details for Attendees
The Shareholders Update Meeting is set for January 8, 2025, at 3:30 p.m. CT (4:30 p.m. ET). Shareholders can conveniently access the meeting online to gain insights directly from the leadership team. The event will facilitate discussions on milestones achieved in the fiscal year and the exciting developments on the horizon for PetVivo Holdings.
How to Access the Webcast
Participants can engage in the live event by registering via PetVivo's Investor Relations platform. Additionally, a link for replay will be available after the session for those unable to attend in real time, ensuring that every shareholder has access to crucial updates. The call can also be accessed with the following details:
Date: January 8, 2025
Time: 3:30 p.m. CT (4:30 p.m. ET)
Dial-in: +1 669 444 9171
Meeting ID: 86782346751
Passcode: 730061
About PetVivo Holdings
PetVivo Holdings, Inc. specializes in creating advanced biomedical devices aimed at providing therapeutic solutions for companion animals. The company is committed to driving innovation in the veterinary market. PetVivo's approach integrates well-researched methodologies for developing technologies that enhance the quality of life for pets, particularly focusing on joint-related ailments.
Innovative Products from PetVivo
The company's flagship product, Spryng with OsteoCushion Technology, is a prime example of innovation targeted at addressing lameness and joint health issues in pets such as cats, dogs, and horses. This veterinarian-administered injectable preparation is designed for optimal efficacy in treating osteoarthritis and related conditions, thereby improving mobility and wellbeing in affected animals.
Importance of Stakeholder Communication
Effective communication with shareholders remains a top priority for PetVivo. The company strongly believes in transparency and keeps its investors well-informed through its Investor Relations website and various disclosure channels. By doing so, shareholders can stay updated on PetVivo's developments, enhancing trust and engagement.
Patented Innovations and Future Directions
PetVivo Holdings boasts an extensive portfolio of patents protecting its groundbreaking technologies and medical devices, solidifying its position in the industry. With a robust pipeline for future products, the company aims to innovate further and increase its impact on animal health and wellness.
Company Contact Information
For those seeking additional details or wishing to connect, John Lai, the CEO of PetVivo Holdings, is available. Interested parties can reach out via email or contact the company directly by phone:
The company can be contacted at (952) 405-6216.
Frequently Asked Questions
What is the purpose of the Shareholders Update Meeting?
The meeting provides an overview of the company's progress and future direction to shareholders.
How can I attend the Shareholders Update Meeting?
You can register and access the meeting via PetVivo's Investor Relations website.
What products does PetVivo Holdings offer?
PetVivo is known for its innovative Spryng product, which is designed for the treatment of joint-related issues in animals.
Who can I contact for more information about PetVivo?
You can contact John Lai, CEO of PetVivo Holdings, for more information.
Where can I find updates about PetVivo Holdings?
Updates can be found on the company's Investor Relations website, press releases, and through SEC filings.
